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Abstract
TAR DNA-binding protein 43 (TDP-43) is a major component within ubiquitin-positive inclusions of a number of
neurodegenerative diseases that increasingly are considered as TDP-43 proteinopathies. Identities of other inclusion
proteins associated with TDP-43 aggregation remain poorly defined. In this study, we identify and quantitate 35 co-
aggregating proteins in the detergent-resistant fraction of HEK-293 cells in which TDP-43 or a particularly aggregate prone
variant, TDP-S6, were enriched following overexpression, using stable isotope-labeled (SILAC) internal standards and liquid
chromatography coupled to tandem mass spectrometry (LC-MS/MS). We also searched for differential post-translational
modification (PTM) sites of ubiquitination. Four sites of ubiquitin conjugation to TDP-43 or TDP-S6 were confirmed by
dialkylated GST-TDP-43 external reference peptides, occurring on or near RNA binding motif (RRM) 1. RRM-containing
proteins co-enriched in cytoplasmic granular structures in HEK-293 cells and primary motor neurons with insoluble TDP-S6,
including cytoplasmic stress granule associated proteins G3BP, PABPC1, and eIF4A1. Proteomic evidence for TDP-43 co-
aggregation with paraspeckle markers RBM14, PSF and NonO was also validated by western blot and by
immunocytochemistry in HEK-293 cells. An increase in peptides from methylated arginine-glycine-glycine (RGG) RNA-
binding motifs of FUS/TLS and hnRNPs was found in the detergent-insoluble fraction of TDP-overexpressing cells. Finally,
TDP-43 and TDP-S6 detergent-insoluble species were reduced by mutagenesis of the identified ubiquitination sites, even
following oxidative or proteolytic stress. Together, these findings define some of the aggregation partners of TDP-43, and
suggest that TDP-43 ubiquitination influences TDP-43 oligomerization.
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Introduction
TDP-43 is a major protein component in ubiquitin-positive,
tau- and a-synuclein-negative inclusions of frontotemporal lobar
degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)
[1,2], which was initially identified due to its specific enrichment in
the detergent-insoluble biochemical fraction of FTLD frontal
cortex [1]. Although physiological TDP-43 is a predominantly
nuclear protein with the capacity to transiently shuttle to and from
the cytoplasm in a manner dependent upon general transcription
[3], pathological TDP-43 redistributes from the nucleus to the
cytoplasm where it more often aggregates following phosphoryla-
tion, ubiquitination and proteolytic cleavage [1,2,4,5]. Despite
recent progress in demonstrating that TDP-43 C-terminal
fragments aggregate in cytoplasm in relative absence of RNA or
dynein-dependent transport [6], a comprehensive understanding
of molecular mechanisms that determine or ensue from TDP-43
aggregation remains elusive. Cultured neurons and HEK-293 cells
expressing full length TDP-43 consistently localize the protein
almost exclusively to the nucleus [7]. In contrast, a potential
naturally occurring human 33.5 kDa N-terminal splicing variant
of TDP-43 (TDP-S6) displays prominent cytoplasmic aggregation
and post-translational modification (PTM) upon over-expression
[7], recapitulating disease phenotype. The splicing event leading to
TDP-S6 mRNA detected in mouse (encoding the protein with
Uniprot ID C9DT14) skips the large, evolutionarily conserved 59
exon encoding the glycine-rich C-terminus of full length TDP-43
which is itself responsible for promoting exon skipping events in
splicing [8], and leads to utilization of a highly conserved
alternative exon with a premature stop codon. Like the mouse
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terminus and is 295 residues in total compared to the full length
protein with 414 residues. The detergent-insoluble biochemical
fraction for TDP-S6 expressing cells accumulated ubiquitin and
SUMO2 or SUMO3 (SUMO2/3) conjugates at high-molecular
weights, whereas the same fraction from TDP-43 overexpressing
cells showed only an increase in SUMO2/3. Compared to TDP-
S6, TDP-43 was more robustly phosphorylated in western blots,
consistent with phosphorylation on two C-terminal serine residues
only present in TDP-43 [7,9].
It is unknown if TDP-43- or TDP-S6-associated post-transla-
tional modifications (PTMs) play a role in the mechanism(s)
underlying TDP-43 proteinopathy because precise identification
of PTM sites and PTM involvement in recruiting interaction
partners to biochemically insoluble aggregates with TDP-43
remains largely unexplored. Mechanisms of TDP-43 aggregation
defined in cellular models, particularly determinants in terms of
primary structure motifs and PTMs on TDP-43 or partners could
provide insight into pathology in more complex tissues. PTMs
generally influence protein-protein, protein-nucleic acid, and/or
protein-membrane interactions by altering or augmenting the
protein surfaces available for stable interactions with select PTM-
sensitive or PTM-dependent partners. For example, ubiquitination
of a protein can enable interactions with ubiquitin receptors
facilitating aggresome formation, or with other receptors that drive
protein flux through the proteasome, or at autophagosomes
accumulating proteins for degradation [10].
The purpose of this study was to determine what interactions
with TDP-43 or TDP-S6 occur in detergent-resistant protein
aggregates to suggest aggregation-associated TDP-43 function,
and to unambiguously identify associated PTMs including TDP-
43 ubiquitination sites. Biochemical fractionation preceding
quantitative mass spectrometry was followed by extensive valida-
tion of TDP-43 or TDP-S6 overexpression-induced cytoplasmic
detergent-insoluble co-aggregate proteins. We also characterized
similarly composed arsenite-induced TDP-43-positive cytoplasmic
stress granules and spontaneous TDP-S6 inclusions in both HEK-
293 cells and primary motor neurons using immunofluorescence
colocalization. Four ubiquitination sites on TDP-43 or TDP-S6
were identified in addition to TDP-43 overexpression-induced
methylation on intrinsically detergent insoluble proteins. An
intriguing and unexpected finding is that the methylation and
ubiquitination events that co-occur during TDP-43 or TDP-S6
overexpression occur primarily on RNA interaction motifs,
suggesting that these PTMs play a role in remodeling the network
of cellular RNPs during protein aggregation which may be an
underlying process in neurodegenerative proteinopathy.
Materials and Methods
Ethics Statement
C57BL6 timed pregnant mice (Charles Rivers) were sacrificed
following ethical standards in the protocol approved by the
Institutional Animal Care and Use Committee (IACUC) at Emory
University.
Reagents
Sodium arsenite, IU-1, and MG-132 for treatment of cultured
cells were respectively obtained from Sigma (St. Louis MO), R&D
Systems/Tocris (Minneapolis MN), and EMD Chemicals/Calbio-
chem (Gibbstown NJ). All other reagents were obtained from
Sigma unless otherwise noted.
Cell transfection and Biochemical Fractionation
Human Embryonic Kidney-293 cells (HEK-293 cells available
from the American Type Culture Collection as CRL-1573)
(,1610
8) were mock transfected or transfected with HA-TDP-
43 or HA-TDP-S6 constructs for 48 hours essentially as described
previously [7]. Cells were washed twice and collected in ice cold
phosphate buffered saline (PBS) and then lysed in ice cold RIPA
buffer (50 mM Tris?HCl pH 7.4, 1 mM EDTA, 150 mM NaCl,
1% (v/v) Triton X-100, 1% (w/v) sodium deoxycholate, 0.1% w/v
SDS). Resulting lysates were spun at 10,0006g for 30 min at 4uC
to generate the detergent-soluble supernatant and insoluble pellet.
Detergent insoluble pellets were dissolved in urea buffer (30 mM
Tris?HCl, 8 M Urea, 2% SDS, pH 8.5). Complete protease
inhibitor cocktail (Roche, Indianapolis, IN) was added to all
buffers immediately prior to use. Buffers for fractionation of lysates
for experiments with TDP-43 ubiquitination site mutants addi-
tionally contained 10 mM iodoacetamide (IAA) and PhosSTOP
phosphatase inhibitor cocktail (Roche). Transfections were
performed using Fugene6 transfection reagent (Roche) according
to manufacturer’s protocol. Protein concentration for all fractions
was determined by Bicinchoninic Acid (BCA) protein assay
(Pierce, Rockford IL) according to the manufacturer’s instructions.
HeLa cells (available from the American Type Culture Collection
as CCL-2), used in place of HEK-293 cells to generate transfected
lysates for supplemental data, were a kind gift of Dr. Keith
Wilkinson.
Primary motor neuron culture and transfection
Primary motor neurons from E13.5 mouse embryos were
isolated, cultured, and transfected by magnetofection as previously
described [11]. Monomeric red fluorescent protein mCherry was
fused N-terminal to human full length TDP-43 or to TDP-S6. To
induce stress granule formation, cells were treated with 0.5 mM
sodium arsenite for 1 hour.
Immunocytochemistry and Antibodies
HEK-293 cells were cultured in Dulbecco’s Modified Eagle’s
medium (Cambrex, Walkersville MD), and supplemented with
10% fetal bovine serum (Gibco, Grand Island NY) and 1%
penicillin-streptomycin (Cambrex). Cells were grown in a humid-
ified 5% CO2 environment at 37uC, and prepared for transfection
by plating on Matrigel-coated coverslips. For overexpressing cells,
immunocytochemistry was performed 48 to 60 hours after
transfection as previously described [12], and cells were often
passed 12–24 h before imaging. Primary antibodies included:
mouse anti-TDP-43 clone 3H8 (1:1000, Abcam, Princeton NJ) (as
indicated for stress granule localization of endogenous or
overexpressed TDP-43; see notes in below paragraph), anti-
HA.11 mAb (1:1000, Covance, Princeton NJ) for tagged, overex-
pressed TDP-43 and TDP-S6 visualization, rabbit anti-G3BP
(1:100, Proteintech Group), rabbit anti-poly(A) binding protein 1,
cytoplasmic antibody (1:30, Abcam), rabbit anti-PSF antibody
(1:100, Abcam), rabbit anti-RBM14 (1:100, Sigma), rabbit anti-
eIF4A1 (1:100, Abcam), rabbit anti-asymmetric dimethyl arginine
(1:25, Abcam), rabbit anti-hnRNP A0 (1:50, Abcam), rabbit anti-
phospho-S409/410-2 TDP-43 (Cosmo Bio Co. Ltd., Tokyo
Japan), and rabbit anti-calnexin (Enzo Life Sciences, Farmingdale
NY) as a loading control. DyLight 549 and Alexa 488 fluorophore-
conjugated cross-adsorbed secondary antibodies were purchased
from Pierce and Jackson Immunoresearch (West Grove PA),
respectively. Images were captured with a 1–2 mm optical
thickness on a LSM 510 confocal microscope (Zeiss, Thornwood
NY) or an Olympus BX51 fluorescent microscope for subsequent
TDP-43 Ubiquitination and Aggregate Proteome
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adjusted using Photoshop CS4 (Adobe, San Jose CA).
In one experiment, 220uC methanol fixation for 2 min
benefited the visualization of G3BP and TDP-43 positive stress
granules with a N-terminal specific monoclonal TDP-43 antibody
(1:200, 60019-2-LG from Proteintech Group), but may have also
decreased the signal from nuclear TDP species. For consistency
with previous staining using paraformaldehyde fixation, all other
visualization of stress granules by immunocytochemistry was
performed with paraformaldehyde, although like the other N-
terminal epitope for TDP-43, the N-terminal HA tag did not
generally image with acceptable contrast or signal-to-noise in
paraformaldehyde-fixed stress granules. Therefore, for many of
the images presented, we used mAb clone 3H8 against TDP-43 as
indicated but confirmed transfection with the HA antibody on
another fluorescent channel after using a triple-labeling technique
that minimizes cross-reactivity of same-species antibodies and
using anti-HA antibody before the pan-TDP-43 antibody.
Specifically, triple staining was performed with mouse anti-
HA.11 overnight followed by first Cy5-conjugated (1:200 for
1 h), then unconjugated (1:50 for 3 h) goat anti-mouse monovalent
Fab (Jackson Immunoresearch), followed by immunochemistry as
described using mouse anti-TDP-43 clone 3H8 and one of the
rabbit antibodies against hnRNP A0, G3BP, PABPC1, or eIF4A1
listed above.
Motor neurons were fixed for 15 minutes with 4 percent
paraformaldehyde in PBS at 3 days in vitro. Mouse anti-TDP-43
(1:1000; Abcam 3H8) and rabbit anti-G3BP (1:100), eIF4A
(1:100), and PABPC1 (1:30) antibodies were incubated overnight
at 4uC. Cy3- or Cy2-conjugated secondary antibodies (Jackson
Immunoresearch) were incubated for 1 h at room temperature. Z-
series (5 to 10 sections, 0.2 mm thickness) were acquired with an
epifluorescence microscope (Ti, Nikon Instruments Inc., Melville
NY) equipped with a cooled CCD camera (HQ2, Photometrics,
Tucson AZ). Images were deconvolved using Autoquant (Media-
Cybernetics, Bethesda MD) and analyzed with ImageJ.
Western Blotting
Immunoblotting was performed according to standard proce-
dures as reported previously [7]. Briefly, samples in Laemmli
sample buffer were resolved by SDS-PAGE before an overnight
transfer to Immobilon-P membranes (Millipore, Bedford MA).
Blots were blocked with TBS plus blocking buffer (USB
Corporation, Cleveland OH) at room temperature for 30 min
and probed with primary antibodies in TBS plus 0.1% Tween-20
plus blocking buffer overnight at 4uC or for 60 minutes at room
temperature. Then, blots were rinsed and incubated with
secondary antibodies conjugated to fluorophores (Molecular
Probes/Invitrogen, Carlsbad CA) for one hour at room temper-
ature. Images were captured using an Odyssey Image Station (LI-
COR, Lincoln NE). Blots visualizing native TDP-43 were
generated using rabbit anti-TDP-43 antibody raised to recombi-
nant TDP-43 (10782-2-AP from Proteintech Group, Chicago IL).
Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR) for Detection of Endogenous TDP-S6
A primer set capable of amplifying both human TDP-43 and
TDP-S6 mRNA was selected from the National Center for
Biotechnology Information reference sequence NM_007375.3 for
TDP-43. The forward or 59 sense primer, 59-ACATCCGATT-
TAATAGTGTTGG-39, occurs in exon 3 while the reverse or 39
primer in exon 6 of TDP-43, 59-ACAGCACTACTTTCAAT-
GAAGTG-39, has its 39 end 32 bp downstream of the TDP-S6
specific junction, which is 100% conserved in TDP-43 mRNA
from the mouse TDP-S6 mRNA (European Nucleotide Archive
sequence ACV52544.1) over 39 bases 59 of the junction and 57
bases 39 of the junction, with 951 intervening bases in the TDP-
43 mRNA. Predicted amplicons for TDP-S6 and TDP-43 were
580 bp and 1531 bp. Total RNA was extracted from three
treatment groups of HEK-293 cells (control, 0.5 mM sodium
arsenite treated for 90 min, or TDP-S6 transfected for 60 h) in
biological duplicate using Trizol reagent (Invitrogen) according to
manufacturer’s protocol. Superscript III one step RT-PCR with
Platinum Taq (Invitrogen) was used according to manufacturer’s
directions with 100 ng RNA input and cDNA synthesis for 20 min
at 53uC. Twenty-five percent of RT-PCR products were visualized
on 3% TAE agarose.
Stable Isotope Labeling with Amino Acids in Cell Culture
(SILAC) and LC-MS/MS
HEK-293 cells were cultured in DMEM (deficient in L-Lysine
and L-Arginine) supplemented with 2% dialyzed fetal calf serum
(Invitrogen) as described [13]. For stable isotopic labeling, heavy
forms L-Arginine (Arg10;
13C6
15N4) and L-Lysine (Lys8;
13C6
15N2) were added (Cambridge Isotope Laboratories, Cam-
bridge MA) to a final concentration of 0.26 mM. Excess proline
was added at 200 mg/L to block arginine to proline conversion
[14]. The RIPA and urea fractions were isolated as described
above. Prior to SDS-PAGE, 10 mg of heavy labeled urea fraction
was added to 10 mg of unlabeled (light) urea fraction from mock,
TDP-43 and TDP-S6 transfected cells. The mixed (light and
heavy) urea fractions were reduced with 10 mM DTT, and
resolved on a 10% polyacrylamide SDS gel. After staining with
Coomassie G-250, one gel lane was cut into three gel pieces
according to molecular weight (#50, 50–100, $100 kDa,
respectively), subjected to in-gel digestion (12.5 ng/ml trypsin).
Extracted peptides were loaded onto a C18 column (75 mm i.d.,
10 cm long, ,300 nl/min flow rate, 3 mm resin from Michrom
Bioresources, Auburn CA) and eluted during a 10–30% gradient
(Buffer A: 0.4% acetic acid, 0.005% heptafluorobutyric acid, and
5% AcN; Buffer B: 0.4% acetic acid, 0.005% heptafluorobutyric
acid, and 95% AcN). The eluted peptides were detected by
Orbitrap (350–1500 m/z, 1,000,000 automatic gating control
(AGC) target, 1,000 ms maximum ion time, resolution
60,000 FWHM) followed by five data-dependent MS/MS scans
in LTQ (2 m/z isolation width, 35% collision energy,
5,000 AGC target, 150 ms maximum ion time) on a hybrid
mass spectrometer (Thermo Finnigan, San Jose, CA). All data
were converted from .RAW files to the .DTA format using
ExtractMS version 2.0 (Thermo) and searched against the
human reference database downloaded from the National Center
for Biotechnology Information (downloaded July 2010) using the
SEQUEST Sorcerer algorithm (version 3.11, Sage-N Research,
Milpitas CA). Searching parameters included mass tolerance of
precursor ions (650 ppm) and product ion (60.5 m/z), partial
tryptic restriction, with a dynamic mass shifts for oxidized Met
(+15.9949), Lys (+8.01420 for
13C6
15N2) and Arg (+10.00827 for
13C6
15N4), four maximal modification sites and two maximal
missed cleavages. Only b and y ions were considered during the
database match. To evaluate false discovery rate (FDR), all
original protein sequences were reversed to generate a decoy
database that was concatenated to the original database (77,764
entries) [15]. The FDR was estimated by the number of decoy
matches (nd) and total number of assigned matches (nt).
FDR=2*nd/nt, assuming mismatches in the original database
were the same as in the decoy database. To remove false positive
matches, assigned peptides were grouped by a combination of
trypticity (fully and partial) and precursor ion-charge state (2+,
TDP-43 Ubiquitination and Aggregate Proteome
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(15 ppm for high-resolution MS), and by dynamically increasing
correlation coefficient (xcorr, minimum 1.0) and DCn (minimum
0.05) values to reduce protein FDR to less than 1 percent. All
MS/MS spectra for proteins identified by a single peptide and
those modified by ubiquitin (lysine +114.0429) or methylation
(lysine or arginine mono: +14.0156, di: +28.0313) were manually
inspected as described previously [16]. Using a second search
algorithm (Mascot), 58 of 59 SEQUEST database match results
for peptides with PTMs were confirmed by re-searching
individual.DTA files on the Matrix Science (Boston, MA) website
(www.matrixscience.com; May 20, 2011) against the full human
database using variable modification settings for the PTMs,
620 ppm peptide (with up to one
13C atom allowed) and
60.6 Da MS/MS tolerances. Importantly, Mascot was able to
discriminate multiple site modified peptides with mixed modifi-
cations, e.g. monomethylation and dimethylation on a single
peptide. The identified proteins/peptides are listed in Tables S1,
S2, S3, S4, and S5. If peptides were matched to multiple
members of a protein family, the matched members were
clustered into a single group. Quantitative pair-wise comparisons
of control, TDP-S6 and TDP-43 transfected cells were carried
out according to a reported method [7]. All peptides with
extracted ion intensity (signal-to-noise) are provided in Table S2,
and all post-translationally modified peptides identified are listed
in Table S4.
Targeted LC-MS/MS for Quantification of Endogenous
TDP-S6 and Related Peptides
Control, 0.5 mM sodium arsenite-treated (90 min), and TDP-
S6 transfected (60 h) HEK-293 (5610
5) cells were harvested in
RIPA buffer, and RIPA-insoluble proteins were solubilized in urea
buffer as described above. All RIPA insoluble protein was loaded
on a 10% SDS-PAGE gel, and proteins below 50 kDa were
excised and digested with trypsin. Peptides were loaded and eluted
off a C18 nanocolumn (75 mm i.d., 10 cm long, 300 nl/min flow
rate) during a reverse-phase LC 10–30% gradient (Buffer A: 0.1%
formic acid, and 1% AcN; Buffer B: 0.1% formic acid, and 95%
AcN) were monitored and fragmented at precursor m/z and
compared to previously identified MS/MS spectra for (a,
F276GGNPGGFGNQGGFGNSR; b, F152TEYETQVK) two
TDP-43 peptides (one, b, shared with TDP-S6), (c,
F276GVHLISNVYGR) one peptide unique to TDP-S6, (d,
D194QIYDIFQK) an eIF4A1 peptide unique to both eIF4A1
splicing isoforms, and (e, H(101 or 138)VFGESDELIGQK; f, V(161 or
198)VLAYEPVWAIGTGK) two triosephosphate isomerase pep-
tides found to be constitutively present at high levels in the
detergent insoluble fraction with no significant effect of TDP-S6
overexpression on quantitation in this fraction, and thus suitable
for normalization. MS/MS settings were: 1.7 m/z isolation width
centered at [(a) 573.28, (b) 864.39, (c) 681.87, (d) 585.80, (e)
730.37, (f) 802.45], 35% collision energy, 5,000 AGC target,
150 ms maximum ion time. Each sample was run in technical
replicate.
Thermo .RAW files were analyzed manually using Qual
Browser 2.0.7 (Thermo). MS/MS signal intensity was summed
for the two or three most prominent fragment ions from each of
the TDP peptides a-c [a1 993.45 (y10), a2 1351.61 (y14); b1 896.44
(y7), b2 767.39 (y6), b3 604.33 (y5); c1 808.43 (y7), c2 695.35 (y6),
c3 921.51 (y8)], and total summed intensity for each peptide was
multiplied by 150 ms/(ion inject time) to cancel out effects of AGC
on MS2 fragment ion intensities, particularly in weak and
multiplexed MS/MS spectra. All fragment ions used for quanti-
fication were required to be present for a positive identification
and accurate quantification. Extracted ion current (XIC) intensity
of the precursor ion not subject to AGC was used to quantify
eIF4A1 and triosephosphate isomerase peptides. Each of the
triosephosphate isomerase peptide intensities was then used to
normalize each TDP or eIF4A1 peptide intensity before calcula-
tion of arsenite-treated/control or TDP-S6 transfected/control
relative intensity. Finally, the two triosephosphate isomerase
peptide-normalized intensities for each of the other peptides were
averaged and presented as log2(experimental/control) 695%
confidence interval.
Structural Alignment
Protein data bank nuclear magnetic resonance-derived struc-
tures of human TDP-43 RRM1 (PDB ID: 2CQG) and RRM2
with bound TAR ssDNA [17] were aligned in Swiss-PDB Viewer
4.0.1 (Swiss Institute of Bioinformatics) using the magic fit
function, resulting in an a-carbon RMSD of 1.12 A ˚ (calculated
for 64 atoms). RRM2 amino acids were masked from view, and
figure images were exported and rendered in POV-Ray 3.7.b38.
External Reference Standard Peptides for TDP-43
Ubiquitination
IAA modification (dialkylation resulting in a 2-acetamidoace-
tamide adduct) of lysine residues in proteins at elevated
temperature prior to trypsin digestion results in a peptide which
is mass-identical to the same peptide modified at the same lysine
residue by ubiquitin [18]; i.e., tryptic digestion of such ubiquitin-
linked isopeptides results in a glycine-glycine tagged lysine
residue with the same atomic composition as lysine epsilon-
amino-diacetamide. pGS21-TDP-43 expressing GST-TDP-43
was transformed into the E. coli BL21 strain and a monoclonal
culture was expanded in 150 mL TB media until reaching an
OD600 of 0.6 and induced for 6 h with 0.1 M IPTG (Sigma, St.
Louis MO) at 28uC. Isolation of GST-TDP-43 and binding to
glutathione sepharose (Amersham, Piscataway NJ) was carried
out according to the protocol of Frangioni and Neel [19]. Protein
on beads was eluted during alkylation in 10 mM IAA (Sigma, St.
Louis MO) for 10 min at 85uC, run in an SDS-polyacrylamide
gel, Coomassie stained for protein weight estimation (5 mgo f
protein banding at 70 kDa), trypsin digested and gel extracted
prior to LC-MS/MS and database search with dynamic
modification of +114.0429 Da on lysine and up to two missed
cleavages. These precursor charge states were then used to
establish a targeted MS/MS method for detection of mass-
identical true lysine-GG peptides. Segments were defined to
increase the robustness of the duty cycle at any given time, i.e.
reduce the number of peptides monitored for multiple charge
states at any given time. A similar LC gradient to the one used
for discovery extending over 60 minutes was employed. Spectra
for the true lysine-GG peptides were confirmed by comparison to
the database-searched pseudo-GG peptide MS/MS spectra, and
by similar relative elution times.
Mutagenesis of TDP-43 and TDP-S6 Plasmids
The Stratagene Quikchange II mutagenesis kit (Agilent, Santa
Clara CA) in combination with PAGE-purified site-specific
primers (IDT, Coralville IA) was used to generate pCDNA3.1
plasmids encoding HA-tagged TDP-43 with point mutations
introducing lysine to arginine substitutions at K102, K114,
K145, and/or K181. All mutants were confirmed by DNA
sequencing.
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Quantitative Proteomics of TDP-43 and TDP-S6
Expressing Cells
Over-expressed human TDP-43 and aggregate prone TDP-S6
with N-terminal HA tags were previously characterized [7]. Over-
expressed TDP-43 has primarily nuclear localization, whereas
TDP-S6 forms highly insoluble aggregates primarily localized to
often large (.10 mm) cytoplasmic structures and smaller (,2 mm)
nuclear structures (Figure 1A). Methods for enrichment such as
immunoprecipitation require a balance in conditions, permitting
solubilization of protein by detergent or weak chaotropes, but
maintaining non-covalent interactions within intact protein
complexes. In contrast, for this study, proteins potentially co-
aggregating with overexpressed TDP-43 or TDP-S6 were
enriched and separated from potential contaminants, which were
removed from the isolated aggregates by detergent-rich (RIPA)
buffer extraction. The detergent insoluble aggregates were then
solubilized in buffer containing 8 M urea and mixed with stable
isotope-labeled internal standard proteins after fractionation (a
strategy to preserve detection capacity for dynamic interactions
[20]). This preceded quantification by unbiased mass spectrometry
to identify and rank both covalent and non-covalent partners
associated with the detergent insoluble fraction including detergent
insoluble aggregates of TDP-43 or TDP-S6.
Detergent insoluble fractions were prepared from untransfected
control stable isotope-labeled (SILAC) HEK-293 cells and three
pools of transfected HEK-293 cells [vector (Mock), TDP-43 and
TDP-S6]. Consistent with previous results following sarkosyl-
detergent extraction [7], TDP-S6 was highly (.95%) detergent
insoluble (Figure 1B). Each of the three transfected insoluble
fractions were subsequently mixed with equal protein weight of
untransfected internal standard (detergent insoluble in replicate 1
or soluble in replicate 2) and characterized by LC-MS/MS
followed by peptide identification and quantitation (Figure 1C).
This differs from the multiplex SILAC approach used previously
[7] in which mixing cells prior to detergent extraction largely
eliminates experimental variability, but potentially masks dynamic,
non-covalent, interactions [20]. Also in contrast to the multiplex
approach, the current method employs the two heavy protein
fractions only as pools of internal standards for quantification of
native peptides and proteins in the detergent insoluble fraction
from transfected cells. This experimental approach, performing
two replicates, with heavy labeled internal standards from either
the detergent soluble or insoluble fraction, and analyzing only two
fractional proteomes at a time, reduces the complexity of each
sample in the mass spectrometer, thus enhancing sampling
coverage of the quantified proteome.
Identification of Detergent Insoluble Proteins
Significantly Changing in Response to TDP-43 and TDP-
S6 Overexpression
Each protein mixture of internal standard and the detergent
insoluble extract of one of the three transfected cell populations
was resolved on an SDS-PAGE gel, excised into three molecular
weight regions, and digested into tryptic peptides. Then each
sample was analyzed by LC-MS/MS on a high-resolution
Orbitrap mass spectrometer. Log2-transformed (native/internal
standard) ratio for proteins quantified in one or more molecular
weight regions of both replicates (soluble and detergent insoluble
internal standard) was calculated using IQUAN software [21] and
produced a list of 585 proteins quantified in the detergent
insoluble fraction of all three transfected cell populations (mock,
TDP-43, and TDP-S6) in both replicates (Table S1). The
quantified protein populations showed a Gaussian distribution in
mock transfected cells, but an uneven or possibly bimodal
distribution in the TDP-43 or TDP-S6 experiments (Figure 1D).
These departures from the normal distribution are consistent with
an effect of TDP-43 or TDP-S6 protein overexpression on the
detergent insoluble proteome due to co-aggregation effects.
From the list of 585 proteins quantified, we present the subset of
proteins (n=41; 35 increasing and 6 decreasing) consistently
changing more than 1.64 times the standard deviation of the mean
(beyond the 95 percent one-tailed confidence interval, or p,0.05)
in the TDP-43 and/or TDP-S6 cell models relative to mock
transfected HEK-293 cells, or in the TDP-43 model relative to
TDP-S6 (Table 1). This significance cutoff for each comparison
respectively fell at 60.91 log2(TDP-43/Mock), 60.89 log2(TDP-
S6/Mock), and 60.65 log2(TDP-S6/TDP-43). To visualize
proteins significantly changing in the TDP-43 and/or TDP-S6
models, we constructed a triple SILAC map [22] of the differences
in log2-transformed ratios (Figure 1E). This map is shown after
recentering differences by subtracting the population means. For
significantly changing proteins along the y-axis, lighter orange
points indicate the magnitude of change of blue points at
equivalent x values in terms of the simpler TDP-S6/Mock ratio.
Confirming a high burden of TDP-43 in the transfected cell
models, we identified TDP-43 as the most enriched detergent
insoluble protein (beyond the top right corner of the map), with an
11-fold increase relative to mock transfection in the TDP-43
model, and an 80-fold increase in the TDP-S6 model. Consistent
with earlier results [7], we found SUMO2/3 enriched in TDP-43
model detergent insoluble extracts and further elevated in TDP-S6
extracts, whereas ubiquitin was specifically enriched in the TDP-
S6 detergent insoluble extract.
In the first three of four groups of changing proteins in Table 1,
significant changes were detected in the detergent insoluble
proteomes for those proteins in either or both of the two
overexpression models compared to mock transfected cells.
Members of the fourth group in Table 1 are designated by the
downward trending arrow ( ) and are enriched with TDP-43
overexpression compared to a relative depletion in TDP-S6
extracts (all below 20.65 log2(TDP-S6/TDP-43), consistent with
interactors of the TDP-43 C-terminal region that is missing in
TDP-S6; some of the group 4 proteins are significantly changed by
other measures in groups 1 to 3 and are not repeated, but rather
are denoted above by an additional diagonal downward arrow.
Interestingly, nine out of the 35 proteins (25.7%) increasing
significantly in TDP-43 and/or TDP-S6 insoluble fractions
contain at least one RRM domain. Manual comparison of MS
spectra for differences in light/heavy ratios in mock, TDP-43 and
TDP-S6 models confirms the changes provided by automatic data
analysis for four such proteins: PABPC1, G3BP, RBM14, and PSF
(Figure 2A). Two of the RRM proteins in Figure 2A co-enriching
with TDP-S6 are PABPC1 and G3BP, whereas the proteins
RBM14, PTB associated splicing factor (PSF), and NonO co-
enriched with TDP-43 and/or TDP-S6. We validated this pattern
of enrichment in the insoluble fraction of biological replicates from
mock, TDP-43, and TDP-S6 transfected HEK-293 cells by
western blot (Figure 2B). These results are consistent with our
proteomics, indicating selective enrichment of G3BP and PABP1
in the TDP-S6 detergent insoluble proteome, and less selective
increases in PSF and NonO with either TDP-43 or TDP-S6
overexpression.
Two recent publications identified full length TDP-43 interac-
tion partners following overexpression and immunoprecipitation
from HEK-293 lysates [23] and stable expression and tandem
affinity purification from HeLa lysates [24]. Comparison of the
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Table 1 that specifically increase in TDP-43 and/or TDP-S6
insoluble extracts (Table 1, right column) indicate that 60 percent
(21 of 35 increasing proteins) overlap with the reported TDP-43
cell model interactomes. It is reasonable to conclude that detergent
extraction of soluble proteins from cell model lysates provides
sufficient enrichment of TDP-43 or TDP-S6 to enable identifica-
tion of TDP-43 interaction partners in the detergent insoluble
fraction of these cells (i.e. the 35 increasing proteins are candidates
for coaggregation with TDP-43 and/or TDP-S6).
In this context, the data set is useful in generating hypotheses
relating to functional crosstalk in discrete compartments or
complexes that harbor the coenriched proteins. For example, a
number of RNA binding proteins known to localize to nuclear
substructures active in splicing function (RBM14, PSF, NonO and
others) are coenriched with TDP-43 and/or TDP-S6. In addition,
cytoplasmic RNA binding proteins which participate in cytoplas-
Figure 1. Characterization of the aggregate proteome of HEK-293 cells overexpressing TDP-43 and aggregate prone TDP-S6. (A)
HEK-293 cells were transfected with HA-TDP-43 or HA-TDP-S6 and immunostained with anti-HA antibody for recombinant TDP-43 exclusively (red)
and Hoescht stain for the nucleus (blue). Scale bars, 10 mm. (B) Western blotting (WB) of native TDP-43 in the detergent soluble (RIPA) and insoluble
(urea) fractions from mock, TDP-43 and TDP-S6 transfected HEK-293 cells. 10 mg and 5 mg of detergent-soluble and insoluble sample were loaded,
respectively. A ponceau S nonspecific band was used to show equal loading. (C) Workflow for quantitative proteomics using isotopic labeled internal
standards. In this approach, detergent insoluble urea extracts from isotopically-labeled control HEK-293 cells are mixed equally with urea extracts
prepared from mock, TDP-43 and TDP-S6 transfected cells. The samples are resolved on an SDS-PAGE gel, excised into gel slices, digested with
trypsin, and analyzed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) on a high-resolution Orbitrap mass
spectrometer. The isotopically labeled peptides from the control HEK-293 cells are chemically identical to their unlabeled counterparts and serve as
internal standards for the measurement of protein abundance across samples. (D) Histograms of the entire population of quantified proteins
expressed as log2(light/heavy) vs. frequency for the three mixtures with Mock (null experiment), TDP-43, and TDP-S6. (E) To visualize proteins
significantly changing in the TDP-43 and/or TDP-S6 models, we constructed a triple SILAC map of the differences in log2-transformed ratios.
Confirming high transfection efficiency, we identified both TDP-43 and TDP-S6 as the most enriched protein component in the cell model (at the top
right).
doi:10.1371/journal.pone.0038658.g001
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38658mic stress granules that have a role in stress-induced translational
repression of housekeeping gene mRNAs [G3BP, PABPC1,
eIF4A1, KHDRBS1/Sam68, and GNB2L1/RACK1 (non-RNA
binding)] also coenriched. This raises the question if overexpressed
TDP-43 or TDP-S6 localize in either paraspeckles or stress
granules, which is addressed in below results sections.
Other novel observations discussed here (but not validated
further) are that TDP-43 more than TDP-S6 preferentially
accumulates with the previously reported interacting 60 S and
40 S ribosomal proteins L5, S3a, L14, P0, and L3, and the nascent
polypeptide chaperone complex represented by Cct7 in group 3.
Group 4 proteins that significantly decrease in the comparison of
TDP-43 to TDP-S6 insoluble proteome include dynein and EWS
(in both groups 3 and 4), as well as RNA helicase A. The latter two
proteins interact in a drug-sensitive nuclear complex [25]. Dynein
enrichment along with ribosomes accumulating with TDP-43
could indicate TDP-43 participation (more than TDP-S6) in RNA
transport granule assemblies associating with ribosomes (since both
60 S and 40 S subunits were enriched) [26]. Translation function
of the ribosome acting on certain mRNAs would be further
enabled by helicase A unwinding of tertiary RNA structure [27].
Thus TDP-43, more tightly than TDP-S6, may link nuclear target
mRNA transcription, splicing, and translation via intact dynein-
dependent mRNA transport function. Conversely, TDP-S6 has
higher co-enrichment with select cytoplasmic factors independent
of elongating core ribosome assemblies that have been shown to
strongly influence ribosome function, including translation initia-
tion factor 4A (eIF4A1) and guanine nucleotide-binding protein
ß2-like 1 (GNB2L1/RACK1) [28] in group 2. Generalizing that
the members of groups 3 and 4 trend down in the comparison of
TDP-43 to the TDP-S6 model, it may be that these proteins’
RNA-directed functions acting on the wide array of TDP-43
associated mRNAs [29] may occur through interactions with the
C-terminus of TDP-43 or via indirect interactions dependent upon
an intact C-terminus not present in TDP-S6. Another discussion
point regarding the decreasing detergent-resistant proteins in both
the TDP-43 and TDP-S6 model including actin and myosin is that
their relative absence with overexpression could be consistent with
a non-stoichiometric accumulation of TDP-43 outside of func-
tional TDP-43 complexes responsible for actin mRNA transport,
translation, or stabilization normally carried out by endogenous
TDP-43 in HEK-293 cells, if not also a relatively partner-
independent role for TDP-43 in the degradation of actin mRNA
[30], or TDP-43 concentration-dependent transcriptional repres-
sion of actin cytoskeleton components.
Recently, TDP-43 negative, FUS-positive FTLD inclusions
were found to contain EWS and TAF15 [31]. We note that these 3
related proteins FUS, EWS, and TAF15 were among the 585
reliably quantified proteins in this study, but our results pose the
interesting implication that overexpressed TDP-43 preferentially
could co-aggregate in HEK-293 cells with EWS [0.99 log2(TDP-
43/Mock)] rather than FUS (0.34) or TAF15 (0.37) (Table S1),
consistent with cell type specific interactions, which may not occur
in the neurons affected in either FTLD or ALS. An equally
plausible alternative to the interpretation of protein-protein
interaction is that TDP-43 overexpression may indirectly and
differentially affect transcription, translation, or post-translational
stability of these intrinsically detergent-resistant proteins that have
potential overlapping function with TDP-43.
Two Stipulations Regarding the Quantification of a
Target Aggregate Proteome
The quantitative approach employed for this study following
qualitative detergent insoluble protein enrichment has two
important caveats that must be addressed. First, qualitatively,
the aggregate proteome is not the entire detergent insoluble
proteome. In fact, the makeup of the mock-transfected detergent
insoluble proteome provides insight into a background level of
proteins that copurify with aggregate proteins. These proteins fall
into categories of possibly ordered protein complexes with
nucleic acid chains (RNPs and chromatin), cytoskeletal proteins,
or mitochondrial organelle contaminants (Figure S1), where
Figure 2. Validation of multiple RNA-binding proteins enriched within the insoluble proteome of TDP-43 and TDP-S6 transfected
HEK-293 cells. (A) Representative quantified peptides from PABPC1, G3BP, RBM14, and PSF in the mock-transfected, TDP-43- and TDP-S6-
ovexpressing detergent insoluble HEK-293 proteome with paired internal standard. (B) Western blot (WB) analysis for, PABPC1, G3BP, PSF and NonO
in the detergent soluble (10 mg) and detergent insoluble (5 mg) proteome of transfected HEK-293 cells. A non-specific band is shown as a control to
confirm equal loading.
doi:10.1371/journal.pone.0038658.g002
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38658Table 2. Functional annotation of enriched proteins in TDP-43 or TDP-S6 detergent insoluble fraction of HEK-293 cells.
Log2 Insoluble Enrichment ±SD
Functional Annotation p-Value Proteins TDP-43/Mock TDP-S6/Mock
processing of RNA 5.05610
227 35 0.83±0.51 0.64±1.06
DDX17
DDX39A
DDX39B
DDX5
HNRNPA0
HNRNPH1
HNRNPH3
HNRNPK
HNRNPL
HNRNPM
HNRNPU
HNRPDL
KHDRBS1
NPM1
PABPC1
PABPC4
PABPN1
PRPF19
PTBP1
RBM39
RPL5
RPL7
RPL14
RPS6
SF3A3
SF3B3
SFPQ
SFRS1
SFRS13A
SFRS3
SFRS6
SFRS7
SFRS9
SSB
TARDBP
U2AF1
biosynthesis of protein 3.03610
213 22 0.71±0.11 0.56±0.38
CALR
DHX9
EEF1A1
EEF1A2
EEF2
EIF4A1
EIF4A2
EIF4A3
GNB2L1
HNRNPK
HSPA5
IGF2BP1
NACA
NCL
PABPC1
PABPC4
PPP1CA
PTBP1
RPS3A
RPS6
SSB
TUFM
translation 3.75610
213 21 0.71±0.11 0.53±0.36
CALR
DHX9
EEF1A1
EEF1A2
EEF2 EIF4A1 EIF4A2
EIF4A3
GNB2L1
HNRNPK
HSPA5
IGF2BP1
NACA
NCL
PABPC4
PPP1CA
PTBP1
RPS3A
RPS6
SSB
TUFM
splicing of RNA 1.00610
212 15 0.89±0.73 0.75±1.55
DDX39A
DDX39B
HNRNPH1
HNRNPH3
HNRNPM
NPM1
PRPF19
PTBP1
SFPQ
SFRS1
SFRS13A
SFRS3
SFRS6
SFRS7
SFRS9
TARDBP
synthesis of protein 3.86610
212 27 0.70±0.14 0.52±0.39
CALR
DHX9
EEF1A1
EEF1A2
EEF2
EIF3A
EIF4A1
EIF4A2
EIF4A3
EWSR1
GNB2L1
HNRNPK
HSPA5
IGF2BP1
KHDRBS1
NACA
NCL
NPM1
PABPC1
PABPC4
PPP1CA
PTBP1
RPS3A
RPS6
SSB
STIP1
TUFM
cell death 1.57610
210 82 0.73±0.35 0.47±0.71
ANP32A
ANXA2
C1QBP
CACYBP
CALR
CCT2
CCT3
CCT4
CCT5
CCT7
CSE1L
CYB5R3
DDX17
DDX3X
DDX4
DDX5
DHX9
EEF1A1
EEF1A2
EEF1D
EEF2
ENO1
EWSR1
FASN
FKBP4
FLNA
GAPDH
GNB2L1
GSTP1
HMGB1
HSD17B10
HSP90AA1
HSP90AB1
HSP90B1
HSPA1A/1B
HSPA5
HSPA8
HSPA9
IGF2BP1
KHDRBS1
MCM2
NCL
NPM1
NUP210
P4HB
PA2G4
PARP1
PCBP2
PCNA
PDIA3
PHB
PPP1CA
PPP2CA
PPP2CB
PRDX1
PRDX3
PRDX6
PRPF19
PRPH
RBBP4
RPLP0
RPS3A
RPS6
RUVBL2
SERBP1
SFN
SOD1
SFRS1
STIP1
STOML2
TARDBP
UBA1
VCP
VIM
XRCC5
XRCC6
YBX1
YWHAB
YWHAE
YWHAG
YWHAQ
YWHAZ
Apoptosis 1.72610
209 66 0.69±0.15 0.41±0.28
ANP32A
ANXA2
C1QBP
CALR
CCT2
CSE1L
DDX17
DDX3X
DDX5
EEF1A2
EEF1D
ENO1
EWSR1
FASN
FKBP4
GAPDH
GNB2L1
GSTP1
HMGB1
HSD17B10
HSP90AA1
HSP90AB1
HSP90B1
HSPA1A/1B
HSPA5
HSPA8
HSPA9
IGF2BP1
KHDRBS1
MCM2
NCL
NPM1
P4HB
PA2G4
PARP1
PCBP2
PCNA
PDIA3
PHB
PPP2CA
PPP2CB
PRDX1
PRDX3
PRDX6
PRPF19
PRPH
RBBP4
RPLP0
RPS3A
RPS6
RUVBL2
SERBP1
SFN
SOD1
SFRS1
STIP1
STOML2
VCP
VIM
XRCC5
XRCC6
YBX1
YWHAB
YWHAE
YWHAQ
YWHAZ
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association were determined using the Database for Annotation,
Visualization, and Integrated Discovery (DAVID) [32]. The
target aggregate proteome is best defined as the proteins which
change quantitatively from the background under conditions that
are expected to alter (in this case, to promote) intermolecular
interactions. Under such conditions, distinct protein species
significantly shift into or from the detergent (solvent) insoluble
fraction, as when TDP-43 intracellular concentration is increased
by overexpression. After cell lysis, solvent makeup, including salts
and a number of additional stabilizers, will affect the fraction-
ation of proteins by changing the balance between pro-
aggregation intermolecular interactions and pro-solvation intra-
molecular folding [33]. The stringent RIPA buffer used here and
an absence of freezing the transfected cell pellets before
fractionation would be expected to maintain the biochemical
segregation of proteins that already occurred in the live cells, by
keeping folded proteins in the detergent-extracted fraction. In
Table 3. Proteins consistently elevated in TDP-S6 detergent insoluble fraction relative to TDP-43.
Log2 Insoluble Enrichment ±SD
A. Proteins from Annotated Functional Categories in Table 2 TDP-43/Mock TDP-S6/Mock
EIF4A1 eukaryotic translation initiation factor 4A, isoform 1 0.81 1.03
EIF4A2 eukaryotic translation initiation factor 4A, isoform 2 0.88 1.09
GNB2L1 RACK1; guanine nucleotide binding protein (G protein), beta 2-like 1 0.72 0.96
HSPA1L heat shock 70 kDa protein 1-like 0.35 0.73
IGF2BP1 ZBP1; insulin-like growth factor 2 mRNA binding protein 1 0.68 0.82
KHDRBS1 Sam68; KH domain containing, RNA binding, signal transduction associated 1 0.41 0.99
PA2G4 EBP1; proliferation-associated 2G4, 38 kDa 0.67 0.77
PABPC1 poly(A) binding protein, cytoplasmic 1 0.76 1.25
PABPC4 poly(A) binding protein, cytoplasmic 4 (inducible form) 0.87 1.46
PARP1 poly (ADP-ribose) polymerase family, member 1 0.54 0.72
PRDX3 peroxiredoxin 3 0.98 1.34
TARDBP TDP-43; TAR DNA binding protein 3.51 6.32
U2AF1 U2 small nuclear RNA auxiliary factor 1 0.96 1.26
VCP valosin-containing protein 0.53 0.69
B. Other Proteins
G3BP1 GTPase activating protein (SH3 domain) binding protein 1 0.00 1.70
LONP1 lon peptidase 1, mitochondrial 0.38 0.70
PSMA4 proteasome subunit, alpha type, 4 0.38 0.71
RAB15 RAB15, member RAS onocogene family 0.00 0.71
RBMX RNA binding motif protein, X-linked 0.47 0.80
RBMXL2 RNA binding motif protein, X-linked-like 2 0.35 0.61
TMPO thymopoietin 0.47 0.73
UBC ubiquitin 20.02 1.35
Symbols for cytoplasmic stress granule proteins or proteins involved in translational repression are indicated by bold, italicized text.
doi:10.1371/journal.pone.0038658.t003
Table 2. Cont.
Log2 Insoluble Enrichment ±SD
Functional Annotation p-Value Proteins TDP-43/Mock TDP-S6/Mock
endoplasmic reticulum
stress response
3.65610
208 10 0.57±0.1 0.44±0.2
CALR
HSPA1L
HSP90AA1
HSP90AB1
HSP90B1
HSPA1A/1B
HSPA5
HSPA6
SERPINH1 VCP
folding of protein 5.21610
208 9 0.63±0.07 0.38±0.16
CALR
CANX
CCT4 HSP90AA1
HSP90AB1
HSPA1A/1B
HSPA5
HSPA8 RUVBL2
doi:10.1371/journal.pone.0038658.t002
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fractions (used for the two replicates strictly as internal standards)
were derived from cells which had been frozen before
fractionation. Freeze-thaw induced aggregation of distinct species
is one explanation for differences in the relative abundance of
some detergent-insoluble proteins between the SILAC (control)
internal standard and mock-transfected group; increased passage
number to accommodate complete labeling is another possible
source of differences. Regardless, the mock transfected/control
distribution of relative protein abundances in the insoluble
fraction remains a normal distribution with the population mean
centered at zero, representing no gross change (Figure 1D).
The second, quantitative, aspect of this study design requires
careful consideration of mass balance. Although SILAC internal
standard and analyte detergent insoluble proteomes were equally
loaded by protein weight, a remaining concern is whether the light
and heavy detergent insoluble protein pools are directly compa-
rable, since the condition promoting aggregation (TDP-43
overexpression) could expand or contract the total protein amount
that is resistant to detergent extraction. This issue of mass balance
underpins whether any quantitation as calculated is reliably
indicating the specified change in protein. In the case of TDP-43
overexpression, mass balance is roughly maintained because the
total protein in the detergent insoluble fraction containing
aggregates does not grossly change as a percentage (about 4
percent) of total cellular protein in lysates of TDP-43 or TDP-S6
transfected vs. untransfected HEK-293 cells [7]. However, if this
experimental workflow is adapted for use in the case of another
protein that more grossly alters bulk protein biochemistry, then
mass balance would not be maintained and additional normali-
zation would be necessary to provide accurate quantitation. In
such a case, the number of cells from which protein is fractionated
could be strictly controlled rather than the mixed protein amount,
so that the target aggregate proteome amount would be allowed to
reflect expansion or contraction. When protein quantity is
properly controlled prior to mixing with internal standard, it
should hold true that if there are bona fide aggregate proteins that
do not change relative to the mock transfected detergent insoluble
proteome, then they lie outside the ‘‘target aggregate proteome’’ of
interest. This does not preclude the presence of aggregates in the
background detergent-insoluble proteome of mock-transfected
cells, but they are not identified by the method employed, because
they present no quantitative change.
Figure 3. Subcellular localization of stress granule proteins coaggregating with TDP-S6 in HEK-293 cells. Immunofluorecence confocal
microscopy analysis of overexpressed HA.TDP-43 or HA.TDP-S6 (red) with endogenous G3BP (A), PABPC1 (B), or eIF4A1 (C) (green) in HEK-293 cells.
Hoechst stain for the nucleus is shown in blue. In panel C, ‘‘T’’ indicates a transfected cell and ‘‘U,’’ untransfected. Scale bars, 10 mm.
doi:10.1371/journal.pone.0038658.g003
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Detergent Insoluble Proteins Confirms a Strong TDP-43
Association with Translation and TDP-S6 with
Cytoplasmic Stress Granule Components
Identifications of 299 proteins increasing moderately or better,
at least 0.5 log2-ratio units (41 percent) in either the TDP-43 or
TDP-S6 aggregate proteome, were input into Ingenuity Pathway
Analysis. Selected output functional annotation categories for
these enriched proteins are given in Table 2, and include a
general RNA processing category, translation, splicing, and cell
death or apoptosis. These categories are consistent with estab-
lished roles of TDP-43, and further implicate protein biosynthesis
or translation, as reported in the soluble TDP-43 interactome [23].
Proteins associated with cell death or apoptosis increasing in the
aggregate proteome with TDP-43 overexpression are also
consistent with evidence that overexpression of wild type, full
length TDP-43 leads to neuronal toxicity in particular [34,35].
However, nuclear fragmentation was not apparent in the vast
majority (.95 percent) of HEK-293 cells transfected up to 72 h
with either TDP-43 or TDP-S6 by immunocytochemistry (data
not shown), so it is not clear whether a shift in these proteins to the
aggregate proteome represents a decrease in cellular survival
mechanisms that progresses to apoptosis. The TDP-S6 model,
which forms the largest TDP-nucleated or -associated aggregates,
has less of an increase in detergent-insoluble death-associated
proteins than the TDP-43 model, consistent with a possible
protective effect.
In fact, for all of the functional categories in Table 2,w e
noted that TDP-S6 aggregate proteins were less enriched than
with TDP-43 overexpression, despite the fact that TDP-specific
peptides were more enriched in the TDP-S6 model. We
therefore asked what the identities are of the proteins that are
at least moderately enriched and are more enriched in the TDP-
S6 model. Surprisingly, this short list of 22 proteins (Table 3)i s
populated by no fewer than ten proteins known to participate in
cytoplasmic stress granules [36,37]. An eleventh protein,
PA2G4/EBP1, similar to eIF4A and GNB2L1/RACK1 in
Table 1 group 2, has a role in modulating translation initiation
complex assembly, in this case via inhibition of eIF2a
phosphorylation [38], posing the possibility that overexpressed
TDP-S6 interacts with PA2G4 and could alter kinase signaling
that accelerates assembly of eIF2-RNA binding-ribosome pre-
initiation complexes, thereby modulating translation rate for
some mRNAs, while cytoplasmic stress granule assembly in
response to many stresses is also strongly influenced by eIF2a
phosphorylation [39]. Consistent with eIF2 complex absence
from stress granule-associated preinitiation complexes [39], the
three eIF2 complex members were quantified by multiple peptide
ratios in the second replicate with spiked-in RIPA-soluble
standard, with no increase evident in the TDP-S6 model
aggregate proteome (data not shown). This is in contrast to
increasing eIF4A1 (Table 1:1.03 TDP-S6/mock log2 ratio),
EIF4G1 (replicate 2:1.60 TDP-S6/mock log2 ratio), and EIF4H
(replicate 2:0.73 TDP-S6/mock log2 ratio).
TDP-S6 Overexpression-associated Inclusion Bodies are
Composed of Common Stress Granule Proteins in HEK-
293 Cells and in Cultured Primary Mouse Motor Neurons
With a preponderance of proteomic evidence indicating a role
for TDP-S6 in altering translation initiation complexes, causing
both core components and modulators to become increasingly
resistant to detergent solubilization, we asked whether TDP-S6-
induced inclusion bodies contain stress granule components such
as G3BP, PABPC1, and eIF4A1, and if any colocalization with
full length HA tagged TDP-43 could be discerned. Immunocy-
tochemistry indicated that TDP-S6 inclusions indeed are strongly
Figure 4. Subcellular localization of stress granule proteins coaggregating with TDP-S6 in primary motor neurons. Left panel shows
localization of G3BP, eIF4A, and PABPC1 (green) in mCherry-TDP-43 overexpressing mouse motor neurons. Right panel, colocalization of the same
stress granule markers with mCherry-TDP-S6 in neuronal soma. Nuclei are stained with Hoechst dye (blue). Scale bars, 10 mm.
doi:10.1371/journal.pone.0038658.g004
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eIF4A1 (Figure 3C), with apparent sequestration from an
otherwise diffuse cytoplasmic distribution. Full length TDP-43
overexpression did not alter the cytoplasmic localization or
patterning of G3BP or PABPC1, although eIF4A1 became
increasingly nuclear with TDP-43 overexpression (Figure 3A,
3B, 3C). Thus, TDP-S6 inclusion bodies resemble cytoplasmic
stress granules in composition of the tested components, even
though they are unconventionally large in size in some cases.
To extend these findings from the proteomics and immunocy-
tochemistry to a model relevant to neuronal proteinopathy, we
performed immunocytochemistry on primary mouse motor
neurons for the same endogenous stress granule markers in the
presence of overexpressed fluorescent-tagged TDP-43 or TDP-S6.
In the absence of any stressful insult, TDP-S6, but not TDP-43,
colocalized in the cytoplasm of the neuronal soma with each of the
stress granule markers (Figure 4). Thus, the accumulation of the
TDP-S6 isoform in neurons is sufficient to nucleate or induce
cytoplasmic formations that contain the stress granule markers
identified in this study in the absence of any exogenous stress other
than TDP-S6 overexpression.
hnRNP A0 enriched in the detergent insoluble fraction of
TDP-43 and TDP-S6 more than two-fold (Table 1) but has not
previously been associated with stress granules or TDP inclusion
bodies to our knowledge. To further test the implications of
aggregate proteome enrichment in our cellular models, we asked
whether hnRNP A0 also participates with TDP-43 or TDP-S6 in
formation of nuclear and cytoplasmic inclusion bodies. Indeed,
although endogenous TDP-43 does not colocalize with hnRNP
A0, grossly overexpressed full length TDP-43 reorganizes hnRNP
A0 nuclear patterning and produces hnRNP A0 colocalization
within nuclear inclusions; TDP-S6 overexpression draws some
fraction of hnRNP A0 from its constitutive nuclear disposition
into cytoplasmic TDP-S6 inclusions (Figure 5). We conclude
that just as TDP-43 overexpression influenced a shift in eIF4A1
to the nucleus (Figure 3C), overexpression of either isoform of
TDP remodels hnRNP A0 protein, although it is not clear if the
functional RNPs of which it is a part are within these inclusions.
Based on all observations of the TDP-S6 model to date, we
conclude that TDP-S6 forms often large (.10 mm) cytoplasmic
granular structures in cells, is conjugated to ubiquitin (possibly
K63 and K48 linked polyUb chains [7]), and these cytoplasmic
structures also minimally include G3BP, PABPC1, and eIF4A1.
Importantly, we were able to confirm these results for the above
three stress granule proteins in primary motor neurons,
suggesting these observations may be relevant to neuronal
degeneration in TDP-43 proteinopathies.
Figure 5. hnRNP A0 colocalization in inclusion bodies positive for overexpressed TDP-43 and TDP-S6 in HEK-293 cells. Endogenous
or overexpressed TDP-43 or TDP-S6 (red) localization relative to endogenous hnRNP A0 (green). In the lower set of images, triple staining was
performed to differentiate overexpressed TDP-S6 from endogenous TDP-43 in a neighboring cell; HA staining not included in the merged image is
shown in magenta. Nuclei are stained with Hoechst dye (blue). Scale bars, 10 mm.
doi:10.1371/journal.pone.0038658.g005
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Granules, but Non-TDP-S6 Form(s) Predominate in HEK-
293 Stress Granules Induced by Arsenite
A number of cellular stresses induce a dynamic convergence of
mRNA transport and packaging factors at stress granules
[36,40,41]. Recent reports have localized TDP-43 in cellular
models to stress granules [23,42–44] and at least one disease
mutation impacts a loss of TDP-43 potentiation of stress granule
formation and functional interaction with G3BP [45], whereas
other familial ALS-linked mutations increase the propensity for
arsenite-induced stress granules to form in a neuroblastoma cell
line, and decrease detergent solubility of the protein in HEK-293
cells, which is strongly and negatively affected by arsenite
treatment as well [43].
We asked if endogenous TDP-S6 might participate in arsenite-
induced stress granules. Since TDP-S6 is constitutively insoluble
(Figure 1B), we compared endogenous levels of a TDP-S6
specific peptide (Figure 6A) from the detergent insoluble fraction
of control and arsenite-treated HEK-293 cells using targeted LC-
Figure 6. Quantification of detergent insoluble TDP-S6 and TDP-43 following arsenite treatment via LC-MS/MS monitoring of the
alternative splicing exon-junction specific TDP-S6 peptide and RT-PCR determination of splicing preference in arsenite-treated
HEK-293 cells. (A) A representative MS/MS fragmentation spectrum of TDP-S6 exon junction peptide F276GVHLISNVYGR, where FG is encoded by
the last two codons of a shortened exon 6 in TDP-S6 and the remainder is encoded by an alternative exon composed of bases usually found in the 39
UTR of TDP-43. The three most intense MS/MS fragment ions on our platform, y6,y 7 and y8 are circled in red. (B) The summed intensity of the ions
circled in (A) was used to quantify TDP-S6 as described in the methods for Targeted LC-MS/MS. Similarly, a TDP-43 specific peptide
(F276GGNPGGFGNQGGFGNSR), and a shared RRM1 peptide F152TEYETQVK were quantified in arsenite-treated HEK-293 detergent insoluble fraction
relative to untransfected, untreated (control) cells. Quantification of the same peptides from the detergent insoluble fraction of TDP-S6 transfected
cells were measured as a positive control. EIF4A1 was also monitored (via peptide D194QIYDIFQK) to show co-enrichment of a stress granule marker
with arsenite treatment or TDP-S6 transfection. Error bars show the 95 percent confidence interval for two replicates. Arsenite treatment (0.5 mM)
was for 90 min. (C) Reverse transcriptase (RT)-PCR of TDP-43 and TDP-S6 mRNA species. RT-PCR was performed on total mRNA extracted from
biological replicates from control or 0.5 mM arsenite-treated (90 min) HEK-293 cells. Primers selected gave predicted TDP-S6 and TDP-43 specific
amplicons of 580 and 1531 bp, respectively. RNA from TDP-S6 transfected cells was used as a positive control.
doi:10.1371/journal.pone.0038658.g006
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positive control. Surprisingly, TDP-S6 significantly increased with
1.5 h arsenite treatment, by 62 percent [a log2(arsenite/control)
MS/MS peak abundance ratio of 0.7060.15; Figure 6B].
However, a peptide specific to other TDP-43 isoforms excluding
TDP-S6 increased significantly more than the TDP-S6 specific
peptide (increasing 380 percent, with a log2 ratio of 2.360.28),
similar to a shared N-terminal peptide residing in both full length
TDP-43 and TDP-S6 RRM1. In contrast, with TDP-S6
overexpression, the TDP-S6 peptide increased 60-fold, and the
peptide that is specific for non-TDP-S6 splice isoforms increased
to an extent similar to the levels seen with arsenite treatment.
These results indicate that endogenous TDP-S6 may also
participate in arsenite-induced detergent-insoluble cellular features
along with TDP-43. The most likely candidate for such features is
stress granules. One explanation for the significantly less robust
increase in TDP-S6 than other TDP-43 isoforms with arsenite
treatment could be the intrinsic low abundance of TDP-S6 relative
to other isoforms; indeed, a rough comparison of relative
abundance provided by the average raw signal intensity for each
of the two exon junction peptides suggests a stoichiometry of 20:3
for endogenous TDP-43:TDP-S6, even in the arsenite treated
insoluble fraction. Moreover, no increase in mature TDP-S6
splicing product is evident via reverse transcriptase PCR of RNA
from 1.5 h arsenite-treated HEK-293 cells relative to controls,
although the mRNA for full length TDP-43 appears to decrease in
abundance (Figure 6C), either due to increased splicing of other
isoforms, a decrease in transcription from the TARDBP locus, or
destabilization of existing TDP-43 mRNA, any of which might
promote the later resolution of stress granules, since TDP-43
stabilizes them [45]. We conclude that there is a possibility that
any increase in total TDP-S6 due to arsenite could be a result of
enhanced translation or stability of existing TDP-S6 mRNA.
However, TDP-S6 could only be measured in the detergent-
insoluble fraction, and TDP-S6 contains all residues necessary for
cytoplasmic aggregation of TDP-43 via intermolecular cysteine
disulfide formation in response to oxidative conditions like those
promoted by arsenite [46], so we cannot completely rule out that
the already highly insoluble TDP-S6 has further shifted into this
fraction as a result of oxidative polymerization.
The other noteworthy finding in Figure 6B (white bar in S6
Transfected/Control comparison) is that non-TDP-S6, TDP-43
protein participation in the detergent insoluble fraction of TDP-S6
overexpressing HEK-293 cells as measured by the exon-exon
junction peptide not present in TDP-S6 increases 560631 percent
over control after TDP-S6 overexpression, even though endoge-
nous TDP-43 transcription or mRNA stability is strongly
downregulated following TDP-S6 overexpression (Figure 6C).
We cannot definitively resolve this paradox within the scope of this
study, but it is tempting to speculate that these results are
consistent with (a) TDP-S6 induced isoform switching to another
TDP-43 splice variant with the same non-S6 exon-exon junction
peptide as full length TDP-43, but without region(s) complimen-
tary to our primers, or (b) a drastic increase in translation
efficiency, protein stability and/or aggregation propensity of
endogenous TDP-43 in the presence of overexpressed TDP-S6,
among other possibilities.
G3BP, PABPC1, and eIF4A1 are also Common
Components of TDP-43 Positive Stress Granules Induced
by Arsenite, Even Following TDP-43 Overexpression
It remained to be tested whether the composition of stress
granules formed due to acute arsenite treatment is similar to that
of TDP-S6 inclusions. Endogenous TDP-43 and/or TDP-S6 is
recruited to arsenite-induced G3BP positive stress granules as
visualized by an N-terminal TDP-43 antibody used on methanol-
fixed HEK-293 cells (Figure 7A). Endogenous TDP-43 coloca-
lization with G3BP in cytoplasmic stress granules was also induced
by arsenite treatment in primary mouse motor neurons
(Figure 7B).
We asked whether other TDP-S6 inclusion body components
are also in the arsenite-induced stress granules of TDP-43
overexpressing cells. This was indeed the case for G3BP
(Figure 8A), eIF4A1 (Figure 8B), and PABPC1 (Figure 8C).
Therefore, although they differ in size, cytoplasmic inclusion
bodies associated with TDP-S6 overexpression and cytoplasmic
arsenite-induced stress granules which include overexpressed
TDP-43 both appear similar in terms of the presence of RNA-
binding proteins that co-aggregate with TDP-S6. In other words, a
tight, multi-hubbed interaction network between TDP-43 and
other RNA binding proteins in stress granules is activated by
cellular stress, but is not required for the same interactions
occurring between these proteins and the TDP-S6 isoform.
TDP-43 and TDP-S6 Colocalize with Nuclear Splicing-
associated RNA and DNA Binding Factors
Three paraspeckle proteins (RBM14, NonO and PSF) involved
in pre-mRNA splicing and transcriptional repression [47,48] were
significantly enriched in the insoluble fraction from both the TDP-
43 and TDP-S6 models (Table 1). However, all three paraspeckle
proteins remained exclusively in nuclear speckles and largely
colocalized with overexpressed TDP-43 (Figure 9), and with
some portion of nuclear but not cytoplasmic TDP-S6 in
representative images (Figure S2). We conclude that proteins
coenriching in the insoluble fraction of the overexpression cell
models, particularly other predominantly nuclear proteins that are
not overexpressed, are likely to exist in a heterogeneous population
of structures that contribute to the TDP-43 and TDP-S6 aggregate
proteome, potentially partly due to indirect effects of TDP-43
overexpression. These data also highlight the heterogeneity of
TDP-S6 localization, varying from mostly cytoplasmic in large
aggregates (Figures 1A, 3A, 3B, 3C) to mostly nuclear in some
cells (Figure S2). In the case of the putative PSF-TDP-S6
interaction, the relative lack of substantial colocalization in
contrast to that seen for nuclear RBM14 and TDP-S6 is noted.
In combination with the finding of biochemical enrichment in the
detergent insoluble fraction, this observation may suggest that an
indirect effect of TDP-S6 overexpression is to increase PSF
association with chromatin; PSF-chromatin interaction is thought
Figure 7. Endogenous TDP-43 participates in arsenite-induced G3BP positive stress granules. (A) Endogenous TDP-43 (green) stained
with an N-terminal monoclonal antibody raised against residues 1–260, and G3BP (red) in control and sodium arsenite (0.5 mM, 45 min)-treated HEK-
293 cells. (B) A small fraction of endogenous TDP-43 (red) localizes to G3BP positive (green) cytoplasmic granules induced by sodium arsenite in
motor neurons. Nuclei are shown in blue. Scale bars, 10 mm.
doi:10.1371/journal.pone.0038658.g007
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complexes, thereby affecting gene-specific transcription rates [49].
Methylation of Constitutively Detergent Insoluble RGG
Motif-containing Proteins Increases with TDP-43 or TDP-
S6 Overexpression
Beyond generating and validating a list of interaction partners
in an aggregate-enriched fraction of overexpressing cells to
complement existing TDP-43 interactomes [23,24,29], we asked
whether our MS/MS spectra harbored any valuable information
about differential PTMs within the aggregate-enriched proteome
of TDP-43 or TDP-S6 overexpressing cells. In addition to RRM
domains, a second common RNA-binding motif, the glycine-rich
Arg-Gly-Gly (RGG) motif, is present in 9 proteins coaggregating
with TDP-43 or TDP-S6 in Table 1. Canonical RGG motifs in a
number of heteronuclear ribonucleoproteins (hnRNPs) of classes
A, B, and C enable them to act as RNA packaging factors, and
these hnRNPs are thought to act on mRNA as histones do on
DNA [50]. Interestingly, the reported hnRNP and TDP-43
interaction partner FUS/TLS that has been genetically and/or
pathologically linked to ALS [51,52] and FTLD [53] harbors a
RGG motif. RGG motifs are frequently asymmetrically dimethy-
lated on the arginine residue such that hydrogen-bonding with the
RNA backbone of specific targets is interrupted, and perhaps this
enables a nonspecific mRNA binding mode [54]. Therefore, we
searched for mono and dimethylation on arginine-containing
tryptic peptides and quantified them in the detergent insoluble
proteomes already sequenced for mock, TDP-43, or TDP-S6
transfected HEK-293 cells. Intriguingly, RGG motifs were in the
major dimethylarginine-containing peptides found (Table 4). The
relative level of the modified peptides was normalized to the
protein expression level (for unmodified peptides); this normaliza-
tion excluded a net increase in what appears to be constitutive
methylation of some proteins in the detergent insoluble fraction
such as hnRNP A0. However a number of other dimethyl-RGG-
containing proteins showed substantial increases in dimethylation
Figure 8. Overexpressed TDP-43 participates in arsenite-induced stress granules. (A–C) Overexpressed TDP-43 (red) localizes to
cytoplasmic granules with redistributed G3BP (A), eIF4A1 (B), or PABPC1 (C) (green) induced by arsenite. Nuclei are shown in blue. Scale bars, 10 mm.
doi:10.1371/journal.pone.0038658.g008
Figure 9. Nuclear paraspeckle proteins colocalize with TDP-43. Immunofluorecence of HA.TDP-43 (red) with endogenous target proteins
(RBM14, NonO, or PSF) in green. Hoescht stain for the nucleus is shown in blue in the rightmost panels of each row. Scale bars, 10 mm.
doi:10.1371/journal.pone.0038658.g009
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transformer-2, FUS, hnRNP U, hnRNP A/B, and THO complex
subunit 4. For example, the MS/MS spectra for coeluting peptides
identifying hnRNP A/B dimethylated at R322 are shown in
Figure 10A (transfected detergent insoluble fraction, upper panel,
and detergent insoluble heavy internal standard, lower panel).
Comparison of the MS spectra for differences in light/heavy ratios
of this peptide in the mock, TDP-43, and TDP-S6 mixtures in
Figure 10B show an unnormalized increase in the modified
peptide in the TDP-43 overexpressing insoluble fraction. The MS
spectrum for a representative unmodified peptide for hnRNP A/B
sequenced in heavy and light forms in all three mixtures displays
little change in the same mixtures (Figure 10C). Thus, the
methylation status for a select subset of RGG motif-containing
proteins which are intrinsically present in the detergent insoluble
fraction may be responsive to the total levels of TDP-43 or TDP-
S6 in the cell or minimally, their levels in the detergent insoluble
biochemical fraction. We confirmed this result and localized
grossly increased dimethyl arginine in the nucleus of cells with
particularly high levels of overexpressed TDP-43 (Figure 11), so it
is likely that the specific increases measured for the population
reflect larger increases occurring in a relatively small fraction of
transfected cells in the model. Lysine residues were also searched
for selective changes in mono-, di-, and trimethylation in the same
detergent insoluble fraction MS/MS data set, but no substantial
changes were observed after normalization (Table S3).
The significance of changes in RGG motif methylation
stoichiometry in the detergent-insoluble fraction of TDP-43
and/or TDP-S6 overexpressing cells is subject to additional
questions. For example, since the identified RNP proteins with
increasing RGG methylation are not in the target aggregate
proteome that changes with TDP-43 or TDP-S6 overexpression,
this may be a response to TDP-43 overexpression that alters
affinity for (possibly promoting) RNA binding in RNPs at a more
global level outside of TDP-43 aggregates. Moreover, increased
occupancy of the methylated form of RGG motifs by RNA that
accumulates in response to TDP-43 overexpression could drive
detergent insolubility and increase the apparent stoichiometry of
the methylated vs. unmethylated forms of these proteins in the
detergent insoluble fraction. Alternatively, TDP-43 has been
Figure 10. A methylated RGG motif peptide increasing with TDP-43 overexpression identified by unlabeled/SILAC peptide
comparison. (A) MS/MS of an hnRNP A/B dimethylated R332 peptide, both unlabeled (upper panel) and heavy (lower panel). (B) MS spectrum for
the peptide in (A) at the LC elution peak from which ion intensities for light and heavy peptides were extracted to calculate Table 4 unnormalized
quantified relative levels of the modification in mock, TDP-43, and TDP-S6 paired experiments. Replicate 1 (urea/urea mixture) spectra are shown. (C)
A representative unmodified peptide for hnRNP A/B (IFVGGLNPEATEEK), the quantified relative levels of which contributed to the normalization
factors in Table 2.
doi:10.1371/journal.pone.0038658.g010
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PRMT2/HRMT1L1 mRNA [29] and TDP-43 overexpression
may thus selectively increase PRMT2 translation, and PRMT2
interacts with hnRNPs [55]. Regardless, we have identified the
possibility that RNA binding in this handful of proteins would be
altered by methylation in response to TDP-43 overexpression
and/or aggregation. Future studies may thus be warranted to
examine if this phenomenon is relevant to mechanisms of
pathogenesis occurring during TDP-43 proteinopathy in neuro-
degenerative disease. It is also possible that differential methyl-
ation at these or similar sites plays a role in the remodeling of
RNPs in response to stress related to RNA accumulation due to
the presence of exogenous, overexpressing genes. With regards to
oxidative stress, we looked for (but did not find) asymmetric
dimethyl arginine in proteins accumulating within cytoplasmic
TDP-S6 inclusion bodies or arsenite-induced stress granules.
Identifying Ubiquitination Sites on TDP-43 with TDP-S6
Ubiquitination alters the fate of proteins, expediting degrada-
tion or changing activity and trafficking, and thereby plays
central roles in neurodegeneration and cancer [56,57]. Identifi-
cation of ubiquitination sites on specific lysine residues of a
protein enables subsequent molecular studies that determine the
effects of ubiqitination on the protein fate. However, discovery of
the lysine residues to which ubiquitin is tethered remains a
bottleneck in this process. Mass spectrometry is the one method
capable of directly ascertaining this information in many cases
where the modified lysine residue retaining an ubiquitin remnant
(glycine-glycine or GG) resides in a region amenable to MS/MS
sequencing following trypsin digestion and missed cleavage at the
GG-modified lysine residue. The peptide harboring the modified
residue must be of length and chemical character so that it can
be sequenced by the MS/MS system chosen (i.e. a proteotypic
peptide). Ubiquitin-like modifications, neddylation and ISG15
modification of proteins at lysine, also produce a Gly-Gly tag.
However, NEDD8 and ISG15 are absent from the list of
proteins co-enriched with either TDP-43 or TDP-S6 in the
detergent insoluble fraction while ubiquitin is coenriched 2.5 fold
with TDP-S6 (Table 1), making it possible to conclude with
confidence that any Gly-Gly tagged TDP-S6 peptides identified
would be most likely due to ubiquitination.
Detergent insoluble TDP-S6 on immunoblots is found in high
molecular weight polymers (Figure 1B), and TDP-S6 colocalizes
with polyubiquitin in aggregate structures by immunofluores-
cence [7]. Therefore, we queried our MS/MS spectra from
mock, TDP-43 and TDP-S6 detergent insoluble fractions using
the SEQUEST database search algorithm for TDP-S6 peptides
that were modified by a Gly-Gly tryptic remnant of the ubiquitin
C-terminus on lysine residues [58]. Mapping ubiquitin attach-
ment sites on TDP-43, TDP-S6 or any ubiquitin substrate is
challenging due to Ub-mediated turnover and a very low ratio of
modified to unmodified substrate. Exploiting high resolution of
60,000 FWHM and mass accuracy (#10 ppm) of the LTQ-
Orbitrap, and the high enrichment factors for both TDP-S6 and
ubiquitin in the TDP-S6 detergent insoluble fraction, it was
possible to initially match three MS/MS spectra using SE-
QUEST with a concatenated target-decoy database, and validate
each spectrum by manual inspection. One MS/MS spectrum for
the K114-Gly-Gly peptide from TDP-43 or TDP-S6 in the TDP-
S6 insoluble proteome is provided in Figure 12A. The spectra
for two other ubiquitin attachment site peptides, K102-Gly-Gly
and K181-Gly-Gly, are provided in Table S5. TDP-S6
sequesters endogenous TDP-43 in TDP-S6 aggregates [7], thus,
these identified sites may be on TDP-S6, endogenous TDP-43,
or both. The three sites and a fourth (K145) identified during
further validation (see below results section) are shown in context
of the TDP-S6 domain map (Figure 12B) and a nuclear
magnetic resonance structure of TDP-43 RRM1 (Figure 12C).
Interestingly, all four ubiquitin conjugation sites are conserved in
TDP-43 homologs from species as divergent as zebrafish; K114,
K145, and K181 are conserved in D. melanogaster, and K145 and
K181 are still conserved in the closest C. elegans TDP-43
homolog.
Figure 11. Increased asymmetric dimethylated arginine in nucleus of TDP-43 transfected HEK-293 cells. Proteins containing
asymmetric dimethylarginine (green) were visualized by immunofluorescence in TDP-43 (red)-transfected and -untransfected HEK-293 cells. TDP-43
overexpression in one cell was confirmed by triple labeling also using the antibody recognizing the HA tag (upper row, rightmost panel). Nuclei are
shown in blue. ‘‘T’’ indicates a transfected cell and ‘‘U,’’ untransfected. Scale bars, 10 mm.
doi:10.1371/journal.pone.0038658.g011
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Dialkylated Lysine Standard
To further validate the ubiquitination sites found and to search
for other GG-remnant peptides missed by shotgun LC-MS/MS,
we chemically derived recombinant purified glutathione S-
transferase (GST)-TDP-43 with two alkyl groups mimicking the
GG remnant on lysine with regards to mass and miscleavage upon
tryptic digestion (producing pseudo-GG peptides and pseudo-GG
MS/MS spectra [18]). These spectra and relative retention times
were then used as an external reference (Table 5), which enabled
us to develop a targeted LC-MS/MS method that we applied to
an additional biological replicate of TDP-S6-transfected detergent
insoluble extracts which were kept free of alkylating agent
(Figure 13A). This approach validated the three spectra obtained
and permitted serendipitous identification of an additional, fourth
GG peptide on TDP-S6 or TDP-43 at K145. Each major MS/MS
fragment ion from the K102 peptide that has lysine with a
114.0429 Da shift due to heat-induced dialkylation (Figure 13B,
left panel) corresponds to a mass-identical fragment from the true
ubiquitin-modified K102-GG peptide (Figure 13B, right panel).
For matches between the other MS/MS spectra, see Table S5.
This method is widely applicable to the discovery of ubiquitination
sites on any protein of interest.
It is of particular interest that all four ubiquitin attachment sites
occur within or near RRM1 of TDP-43. We note that there are
four additional potential ubiquitination sites in RRM1 that do not
fall within proteotypic tryptic peptides and could not be sequenced
(K136, 137, 140, and 176). Moreover, a recent proteome-wide
study in HEK293T cells found K102 and K114 as well as K160 to
be ubiquitinated [59], and these sites were further confirmed in a
second recent high-throughput study which also identified
Figure 12. Identification of ubiquitin sites on TDP-43 by mass spectrometry. (A) Trypsin digestion of ubiquitin conjugates generates a di-
glycine tag (GG), with a monoisotopic mass of 114.0429 Da) on ubiquitin-modified lysine residues, producing unique MS/MS spectra that can be
matched by SEQUEST. Searching against a concatenated target-decoy database followed by manual validation, three sites of lysine ubiquitination
(K102, K114 and K181) were mapped to TDP-43 in the TDP-S6 insoluble proteome. A fourth site (K145) identified later is also shown. (B)
Ubiquitination site context in the linear domain structure of TDP-S6 is shown. (C) Two views rotated about the y-axis of a three-dimensional model of
RRM-1 docked to HIV TAR ssDNA (blue) modified from Kuo, et al [17]. K102, K114, K145, and K181 side chains are labeled and explicitly shown (purple)
in the context of the RRM-1 domain structure. The closest e-amino group to the nucleic acid backbone (3.1 A ˚) was K181, which resides in the loop
that follows the RRM1 C-terminus.
doi:10.1371/journal.pone.0038658.g012
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as many as 11 distinct TDP-43 lysine residues [60]. So, it is
possible that RRM1 lysine residues in general are preferential, if
not interchangeable, ubiquitination targets. The K160 ubiquitina-
tion product was reported to occur in response to proteasome
inhibition, whereas no proteasome inhibition was used in our
studies.
Phenotypes of TDP-43 and TDP-S6 Ubiquitin Site Mutants
We hypothesized that RRM1 ubiquitin attachment could limit
the degrees of freedom of motion between RRM1 and other parts
of the protein, thereby affecting intramolecular interaction
between RRM1 and RRM2 in a TDP-43 monomer. Intra- and
intermolecular interactions between RRM domains have been
reported in a number of dual-RRM containing factors, and one
structural study found that TDP-43 RRM2 intermolecular
Figure 13. Dialkylated peptide standard development for discovery and validation of ubiquitinated lysine peptide MS/MS spectra.
(A) Workflow for generating pseudo-ubiquitinated peptides. Peptides for all spectra generated and detected are listed in Table 5. (B) Comparison of
MS/MS fragmentation spectra for the K102 pseudo-GG containing peptide (left panel) and the true K102-GG peptide (right panel). Spectra of all true
lysine ubiquitination site peptides, side-by-side with those for pseudo-GG peptides, are given in Table S5.
doi:10.1371/journal.pone.0038658.g013
Table 5. Dialkylated reference peptides for determination and validation of ubiquitin attachment sites on TDP-43.
Site of TDP-43
attachment to
ubiquitin Peptide Sequence Charge XCorr DCn
Matched
Ions
M+H
Precursor
Targeted MS/MS
Method Segments*
K84 R.K
+114M
OxDETDASSAVK.V 2 2.31 0.35 14/22 1411.6369 1
K84 R.K
+114MDETDASSAVK.V 2 2.79 0.49 13/22 1395.6420
K95 K.M
OxDETDASSAVK
+114VK.R 2 3.95 0.14 19/24 1510.7053
K95 R.KMDETDASSAVK
+114VK.R 2 4.01 0.10 18/26 1622.8054
K181 K.LPNSK
+114QSQDEPLR.S 2 3.46 0.49 16/24 1625.8241
K160 R.FTEYETQVK
+114VM
OxSQR.H 2 3.53 0.54 17/26 1875.8905 2
K160 R.FTEYETQVK
+114VMSQR.H 2 4.03 0.61 20/26 1859.8956
K145 K.TGHSK
+114GFGFVR.F 2 2.38 0.55 15/20 1306.6651
K136 K.EYFSTFGEVLM
OxVQVK
+114K.D 2 3.84 0.07 18/30 2035.0204
K102 R.AVQK
+114TSDLIVLGLPWK.T 2 5.34 0.56 23/30 1882.0796 3
K114 K.TSDLIVLGLPWK
+114TTEQDLK.E 2 3.97 0.25 23/36 2271.2230
K224 R.EFFSQYGDVM
OxDVFIPK
+114PFR.A 2 2.39 0.55 16/36 2452.1641
K121 K.TTEQDLK
+114EYFSTFGEVLM
OxVQVK.K 3 4.13 0.54 27/84 2722.3280 4
K121 K.TTEQDLK
+114EYFSTFGEVLMVQVK.K 3 3.17 0.42 21/84 2706.3330
*Peptides are listed by retention time/elution order from reverse phase C18 nano-LC column.
doi:10.1371/journal.pone.0038658.t005
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evidence for intermolecular cysteine disulfide formation across
RRM2 domains [46]. To test if RRM1 ubiquitination alters the
solubility or oligomerization propensity of TDP-43, we mutated
the four potential ubiquitin-bearing lysines that we identified in
TDP-43 and TDP-S6 RRM1 (K102R/K114R/K145R/K181R,
‘‘4R’’) and compared the efficiency of RIPA detergent extraction
of HEK-293 cells overexpressing wild type (WT), 4R, 3R, and 2R
mutants of TDP-43 and TDP-S6 by western blotting extracts
equally loaded by protein weight as determined by BCA assay.
The result shown in Figure 14A [western blot for N-terminal HA
tag, with calnexin (CN) signal for loading control] indicates that
TDP-S6 solubility in RIPA increases considerably for the 4R
mutant relative to wild type TDP-S6, and that the TDP-S6 4R
mutant has decreased detergent-insoluble polymerized TDP bands
at 90–100 kDa and .150 kDa, even relative to the 3R and 2R
mutants. TDP-43 4R mutations modestly decreased high molec-
ular weight polymerization in the both the RIPA-soluble and -
insoluble fractions, and may have an additional negative effect on
accumulation of the HA-tagged phosphorylated species at 50 kDa
and higher molecular weight bands, which we confirmed in a
replicate blot with anti- pS409/pS410-TDP-43 (Figure S3). Even
though deubiquitinase activity was inactivated by IAA, we noted
that in WT TDP-43, there is only a faint steady state band at the
expected location of monoubiquitinated (or SUMOylated)
HA.TDP-43 ({ in Figure 14A) or HA.TDP-S6 bands corre-
sponding to mono, di-, and tri-ubiquitinated species (*, **, and ***
in Figure 14A). Consistently, these bands are further diminished
by K-to-R substitutions at the 4 ubiquitination sites identified
(Figure 14A, left panel). We conclude that modification of TDP-
43 by ubiquitin or ubiquitin-like proteins, and particularly of
TDP-S6, may induce or follow polymerization into high molecular
weight detergent-insoluble species.
We asked whether the decrease in polymerization of TDP-43
with ubiquitination site mutation might correspond with a
resistance to oxidative polymerization of the mutant protein in
response to oxidative stress (arsenite, [46]) in the detergent-
insoluble fraction of HEK-293 cells. To answer this question, we
repeated transfection of WT and 4R TDP-43, and 1 hour before
harvest, we treated cells with 0.5 mM arsenite. Indeed, accumu-
lation of detergent-insoluble ubiquitinated and polymerized TDP-
43 was decreased not only basally, but also was strikingly absent in
the 4R mutant cells detergent insoluble fraction following arsenite
exposure (Figure 14B, lower left panel). Finally, to address
Figure 14. Biochemical fractionation of TDP-43 and TDP-S6 into detergent soluble and insoluble fractions is altered by the
cumulative mutation of the four identified RRM1 lysine ubiquitin attachment sites on TDP-43 and TDP-S6. (A) Western blot of the N-
terminal HA tag (upper panel) on overexpressed TDP-43 or TDP-S6 in HEK-293 extracts indicates a change in high molecular weight species and
ubiquitinated species of the overexpressed proteins. Right panels give a lower exposure of the same blot. Expected positions of monoubiquitinated
TDP-43 ({), and mono-, di- and tri-ubiquitinated TDP-S6 (*, **, ***) are indicated. 18 mg of RIPA extract and 3 mg of RIPA-insoluble (urea) extracts were
loaded. WT, wild type; 4R (K102R/K114R/K145R/K181R); 3R (K102R/K114R/K181R); 2R (K102/K181R for TDP-43 and K114R/K181R for TDP-S6). (B)
Detergent-fractionated HEK-293 cell extracts from cells transfected with equal amounts of WT or 4R TDP-43 were immunoblotted for the N-terminal
HA tag. Where indicated, cells were treated for 1 h with 0.5 mM sodium arsenite. {, the expected position of monoubiquitinated TDP-43 is indicated.
Western blot signal for calnexin (CN, 90 kDa) is provided as a loading control.
doi:10.1371/journal.pone.0038658.g014
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cell types other than HEK-293 cells, we performed a similar
experiment in HeLa cells. In addition, we asked whether the
decreases in ubiquitination and polymerization of TDP-43 or
TDP-S6 K-to-R mutants were resistant to an additional treatment
which promotes increases in TDP-43 ubiquitination (USP14
deubiquitinase inhibition plus proteasome inhibition 6 h before
harvest of cells, [61]). Figure S4 demonstrates that indeed, the 4R
RRM1 ubiquitination site mutant of TDP-43 has decreased
accumulation of detergent-insoluble high molecular weight species
of the overexpressed protein exposed to oxidative or proteolytic
stress in HeLa cells. The residual band at the expected molecular
position of monoubiquitinated TDP-43 4R mutant ({ in Figure
S4) is consistent with the existence of additional lysine residues on
TDP-43 suitable for ubiquitin or ubiquitin-like modifier conjuga-
tion during stress, as already reported in global proteomic studies
[60].
Further studies are warranted to identify E3 ubiquitin ligase(s)
that target RRM1 of TDP-43 during pathogenesis. If inhibition of
these enzymes can be achieved, disease course may be altered.
Evidence further suggests that ubiquitin dynamics on RRM1 of
TDP-43 may also coordinate its participation in aggregates with
oxidized polymers. This data suggests an intriguing role for
ubiquitination of TDP-43 RRM1 in its participation in stress
granules and paraspeckles, with potential effects on nucleation,
assembly or disassembly, and thereby would respectively affect
translation and transcription-coupled splicing in response to
cellular conditions inducing such ubiquitination. Precedent for a
role of ubiquitination of an RNA-binding protein affecting
translation in neurons at dendrites with effects on learning and
memory was recently published by the Kandel group [62], and as
TDP-43 RNA transport and translational control has also been
shown to respond to neuronal activity [30], it will be key to identify
if ubiquitination of TDP-43 plays a similar regulatory role.
Concluding Remarks
This study presents significant advances in the characterization
of TDP-43-associated PTMs and potential effects of TDP-
43 PTMs on phenotypic changes in proteins with RRM and
RGG RNA-binding domains. The four sites of direct ubiquitin
conjugation to TDP-S6 at residues K102, K114, K145, and K181
are conserved with the RRM1 fold in TDP-43 homologs,
consistent with a yet unappreciated role or roles in TDP-43
function. The TDP-S6 target aggregate proteome, which accu-
mulates non-degradation-associated K63 and to a lesser extent
K48 ubiquitin linkages [7] contrasts with the enrichment of
SUMO2 and/or 3 and its colocalization with overexpression of
nuclear TDP-43 [7]. We speculate that the small fraction of full
length TDP-43 transiting outside the nucleus [3] would be
exposed to functional modulation by a cytoplasmic E3 ubiquitin
ligase. In the case of ubiquitination on RRM1, data from this
study suggests that this PTM has a role in promoting TDP-43 self-
interaction in detergent-insoluble aggregates, particularly in
response to oxidative stress (Figure 14), and these aggregates
include other RNA-binding proteins, the solubility of which might
also be affected by TDP-43 ubiquitination. The context of
attachment sites in the structure of RRM1 (Figure 12C) suggests
that RNA binding by TDP-43 itself would likely be modified by
ubiquitination.
Ubiquitin conjugate accumulation, insolubility of TDP-43 in
aggregates or inclusions, and cleavage fragments of TDP-43 have
been found to occur during the pathogenesis of TDP-43
proteinopathies including ALS and FTLD, as well as in diseases
not previously associated, including Alzheimer disease, Machado-
Joseph disease, and Parkinson disease [63–73]. In this study, we
have identified an intersection between the interactions of RNA
binding proteins and ubiquitination, and our data are consistent
with a model wherein this intersection lies just upstream of
translation and/or translational inhibition. The choice for TDP-43
to deliver and release mRNA to translation preinitiation
complexes or to inhibit mRNA translation could absolutely
depend on the presence or absence of conditions to which TDP-
43 conformation is sensitive, such as oxidative redox balance [46]
or the accumulation of similar aggregate-prone proteins in a
destabilized, or even prion-like state. Ubiquitination of TDP-43
RRM1 appears to promote or coincide with such a state, and it is
likely not by chance that many of the co-aggregating RNA-binding
proteins we detected also contain prion-like domains [74]. A
timeline of kinetics for TDP-43 ubiquitination under different
conditions, splice variant expression, and participation in distinct
cytoplasmic and nuclear aggregates in future studies will provide
further insight into mechanisms of pathogenesis in neurodegen-
erative diseases.
Supporting Information
Figure S1 Protein groups in the background detergent
insoluble proteome and those significantly changed in
the TDP-43 and TDP-S6 target aggregate proteomes.
Protein categories defined by DAVID version 6.7 were graphed as
a percentage of the population of the 585 proteins identified in
Table S1 (grey bars), and for the 41 significantly changing proteins
in Table 1 (red bars, increasing; green bar, decreasing).
(TIF)
Figure S2 Costaining of Nuclear RNA-binding proteins
with TDP-S6. (A, B) HA.TDP-S6 (red) colocalization with
nuclear PSF (A), arrow, or RBM14 (B) in distinct subnuclear
structures in representative cells. PSF and RBM14 staining are
shown in green. Scale bars, 10 mm.
(TIF)
Figure S3 Phospho Ser409/Ser410 TDP-43 decreases in
the insoluble fraction with ubiquitination site removal
via mutation of lysine to arginine. Western blot of the same
membrane for HA.TDP-43 (anti-HA, left panel) and phospho
Ser409/Ser410 of TDP-43 (right panel).
(TIF)
Figure S4 Quadruple TDP-43 ubiquitin site mutant is
resistant to oligomerization following oxidative or
proteolytic stress in HeLa cells. Detergent-fractionated
HeLa cell extracts from cells transfected with equal amounts of
WT or 4R TDP-43 and treated as indicated for 1 h with sodium
arsenite or 6 h with MG-132 plus IU1 were immunoblotted for
the HA tag. {, the expected position of monoubiquitinated TDP-
43 is indicated. Western blot signal for calnexin (CN, 90 kDa) is
provided as a loading control.
(TIF)
Table S1 Quantification of 585 proteins in both exper-
imental replicates. All proteins quantified by light/heavy
peptide ratio in both experimental replicates (insoluble/insoluble
and insoluble/soluble experimental/standard light/heavy mix-
tures) are listed. Standard deviation across all quantified peptides
of each protein is given along with the number of quantified
peptides, and average signal to noise ratio of the quantified
peptides for each of six light/heavy mixtures. Mean normalization
factors for recentering population data are given on the darkened
header row above each of the six log2(light/heavy) data columns.
(XLS)
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PLoS ONE | www.plosone.org 26 June 2012 | Volume 7 | Issue 6 | e38658Table S2 All proteins and peptides identified by LC-
MS/MS of mock, TDP-43, or TDP-S6 transfected
detergent insoluble fractions. Total number of spectral
counts (SC), the number of unique peptides assigned on each
protein, sequencing coverage (%), the mass error measured in
Orbitrap (deltaMass), the SEQUEST matching scores (XCorr and
deltaCn), the link to assigned spectra, and where calculated,
extracted ion current intensity expressed as signal-to-noise ratio for
paired light and heavy peptides in mixtures are listed. The labeled
heavier K or R residues are marked (@, #).
(ZIP)
Table S3 Lysine methylation site peptides identified
and quantified in the TDP-43 and TDP-S6 insoluble
proteome of HEK-293 cells. Histone and elongation factor Tu
methylation sites were identified without any quantified change
due to TDP-43 or TDP-S6 overexpression. Note that H3
methylation sites are numbered on the mature histone without
Met1. Ion suppression affected the four WT TDP-43 histone H3
XIC intensities in a single LC-MS/MS run relative to the
comparable TDP-S6 and Mock runs. This suggests that extra
caution must be taken when quantifying peptides without an
internal standard.
(XLS)
Table S4 Identification of methylated and ubiquiti-
nated proteins and peptides. All peptides identified by MS/
MS to harbor PTMs in this study are listed with the mass error
measured in Orbitrap (deltaMass), the SEQUEST matching
scores (XCorr and deltaCn) and matched ion count. The labeled
K or R residues are marked as follows: dimethyl-Lys (@), methyl-
Lys ( ˆ ), dimethyl-Arg (#), Lys-epsilon-amino-GG (ubiquitination,
&).
(XLS)
Table S5 Comparison of pseudo-GG peptide MS/MS
spectra obtained by LC-MS/MS of IAA-alkylated GST-
TDP-43 and bona fide TDP-43 or TDP-S6 GG peptide
spectra. Sequest matched ions are shown on MS/MS spectra for
pseudo-GG peptides obtained for purified GST-TDP-43. Where
available to the right, representative lysine-GG peptide spectra
sequenced from the urea-solubilized detergent insoluble fraction of
TDP-S6 overexpressing HEK-293 cells (K102-GG, K114-GG,
K145-GG, and K181-GG) are also shown to the right. The K145-
GG peptide mascot spectrum and matched ions table are also inset
to the right.
(XLS)
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